SeaStar Medical Holding Corporation (NASDAQ:ICU) Short Interest Update

SeaStar Medical Holding Corporation (NASDAQ:ICU) saw a significant drop in short interest during the month of February. As of February 27th, there was short interest totaling 233,272 shares, a drop of 18.5% from the February 12th total of 286,335 shares. Based on an average daily trading volume, of 43,336 shares, the short-interest ratio is currently 5.4 days. Currently, 6.2% of the shares of the company are short sold. Currently, 6.2% of the shares of the company are short sold. Based on an average daily trading volume, of 43,336 shares, the short-interest ratio is currently 5.4 days.

SeaStar Medical Stock Down 3.0%

ICU stock opened at $2.56 on Friday. SeaStar Medical has a 52 week low of $2.20 and a 52 week high of $25.70. The business has a 50-day simple moving average of $2.50 and a 200 day simple moving average of $4.48. The company has a market cap of $9.70 million, a PE ratio of -0.16 and a beta of -1.04.

Wall Street Analysts Forecast Growth

ICU has been the topic of a number of recent analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of SeaStar Medical in a report on Thursday, January 22nd. Maxim Group set a $6.00 price objective on shares of SeaStar Medical in a research report on Thursday, February 12th. Finally, Wall Street Zen upgraded shares of SeaStar Medical to a “hold” rating in a report on Saturday, January 10th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell” and a consensus target price of $6.00.

Institutional Trading of SeaStar Medical

A number of institutional investors and hedge funds have recently made changes to their positions in ICU. XTX Topco Ltd boosted its position in shares of SeaStar Medical by 395.4% during the 2nd quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock worth $26,000 after acquiring an additional 48,674 shares in the last quarter. Trinity Financial Advisors LLC increased its stake in SeaStar Medical by 233.3% in the third quarter. Trinity Financial Advisors LLC now owns 50,000 shares of the company’s stock valued at $28,000 after acquiring an additional 35,000 shares during the last quarter. Millennium Management LLC acquired a new position in SeaStar Medical during the third quarter valued at approximately $102,000. Finally, Jane Street Group LLC bought a new stake in SeaStar Medical during the fourth quarter worth $30,000. Institutional investors own 1.69% of the company’s stock.

About SeaStar Medical

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.